Reshoring with Robotics & Bridging the Labor Gap
May 19, 2023
Read Time 3 MIN
The affordability and capabilities of robots have led to their widespread adoption in many different industries, making them an essential part of our daily lives. Robotics technology will continue to revolutionize the way we work by automating mundane and dangerous tasks that previously required humans to perform. As businesses strive to stay competitive and meet the demands of their customers, the need for robotics continues to grow. From manufacturing and healthcare to logistics and agriculture, robots are now an integral part of many industries.
With a growing number of applications, the industrial robotics industry presents a compelling investment opportunity. This industry involves tasks like designing, developing, manufacturing, and selling robots or robotics systems for a wide range of applications. The cost-effectiveness of robots, along with advancements in technology and demographic shifts, have created a favorable environment for investors to consider this rapidly growing sector.
Robotics Affordability: More Bang, Fewer Bucks
In recent years, the significant improvement in the cost-effectiveness of robots can be attributed to remarkable technological advancements. These advancements have led to the development of more efficient and affordable robots capable of executing a wide range of tasks with precision and accuracy. This has made automating robotics tasks easier for companies to achieve a return on investment.
Average Cost of Industrial Robots
Source: Statista. As of 2022.
Reshoring: Can Robotics Revive Domestic Manufacturing?
Companies can now consider reshoring their manufacturing operations with robots' increased affordability and capability. This trend of bringing production back home from overseas is being fueled by the ability of customized robots to be quickly programmed and integrated into operations, providing greater flexibility and scalability. Despite companies not previously considering reshoring due to high costs and limited robot capabilities, advancements in technology and increased efficiency have made robot installation more feasible. As a result, reshoring has become a viable option for companies, paving the way for a potential shift in manufacturing from offshore to domestic locations.
New Robotics Tech: Fueling Demand Across Industries
Rapidly growing technology has strengthened the demand for robotics. Advancements in user-friendly interfaces, programming languages, and sensor technologies have made robots become more intuitive and easier to operate. Keyence Corp’s (TYO: 6861) vision-guided robots exemplify this cutting-edge technology through streamlining tasks, boosting productivity, and minimizing changeover delays. These advancements have enhanced production efficiency and broadened the scope of robot implementation across various sectors, including healthcare, logistics, and agriculture.
Industrial Robotics: Solution to an Aging Population and Labor Shortage
Demographic factors are playing a role in the growing use of industrial robotics. With many countries seeing a dwindling labor force and declining birth rates, companies struggle to find skilled workers to meet production demands. The aging population in countries such as China has led to higher labor costs and a shortage of workers. To tackle these challenges, businesses are turning to automation and robotics as a solution. Several robotics companies are responding to this demand by expanding operations in China. ABB (NYSE: ABB) opened up a $150M robotics mega factory in Shanghai in December of 2022 solidifying its robotics and automation leadership in the region. It is imperative for robotics companies to continue investing in regions confronting such demographic challenges.
China’s Population is Growing Older by 2050
Source: United Nations. As of 2022.
VanEck Robotics ETF (IBOT) offers concentrated exposure to the promising investment opportunity in the robotics industry, fueled by the widespread adoption of robots in various industries and sectors. The fund seeks to track a diversified index emphasizing the many subthemes in robotics. Enhanced affordability and advanced capabilities of robots have played a pivotal role in fueling this adoption, making them an attractive option for those seeking long-term growth in the field.
To receive more Thematic Investing insights, sign up in our subscription center.
Keyence Corp is 5.58% of IBOT net assets as of 5/15/23.
ABB Ltd is 5.31% of IBOT net assets as of 5/15/23.
This is not an offer to buy or sell or a recommendation to buy or sell any of the securities/financial instruments mentioned herein. The information presented does not involve the rendering of personalized investment, financial, legal, or tax advice. Certain statements contained herein may constitute projections, forecasts and other forward-looking statements, which do not reflect actual results, are valid as of the date of this communication and subject to change without notice. Information provided by third party sources are believed to be reliable and have not been independently verified for accuracy or completeness and cannot be guaranteed. VanEck does not guarantee the accuracy of third-party data. The information herein represents the opinion of the author(s), but not necessarily those of VanEck or its employees.
An investment in the Fund may be subject to risks which include, among others, investing in the robotics industry, information technology sector, industrials sector, equity securities, medium-capitalization companies, Japanese issuers, foreign securities, semiconductor industry, depositary receipts, market, operational, index tracking, authorized participant concentration, new fund, no guarantee of active trading market, trading issues, passive management, fund shares trading, premium/discount and liquidity of fund shares, non-diversified and concentration risk, all of which may adversely affect the Fund. Medium-capitalization companies may be subject to elevated risks.
BlueStar® Robotics Index is the exclusive property of MarketVector Indexes GmbH (a wholly owned subsidiary of Van Eck Securities Corporation), which has contracted with Solactive AG to maintain and calculate the Index. Solactive AG uses its best efforts to ensure that the Index is calculated correctly. Irrespective of its obligations towards MarketVector Indexes GmbH, Solactive AG has no obligation to point out errors in the Index to third parties. The VanEck Robotics ETF is not sponsored, endorsed, sold or promoted by MarketVector Indexes GmbH and MarketVector Indexes GmbH makes no representation regarding the advisability of investing in the Fund.
An investor cannot invest directly in an index. Returns reflect past performance and do not guarantee future results. Results reflect the reinvestment of dividends and capital gains, if any. Certain indices may take into account withholding taxes. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.
Investing involves substantial risk and high volatility, including possible loss of principal. An investor should consider the investment objective, risks, charges and expenses of a Fund carefully before investing. To obtain a prospectus and summary prospectus, which contain this and other information, call 800.826.2333 or visit vaneck.com. Please read the prospectus and summary prospectus carefully before investing.
© Van Eck Securities Corporation, Distributor, a wholly owned subsidiary of Van Eck Associates Corporation.
May 24, 2023
Thematic InvestingMore from this category View More
May 24, 2023
May 22, 2023
Domestic equities traded within a narrow range as investors debated the impact of a weakening U.S. economy; mixed Q1 earnings provided no clear outlook for the market.
May 18, 2023
Israel, celebrating its 75th Anniversary, remains positioned for sustained economic growth due to its demographics, GDP growth, thriving consumer discretionary sector, and cutting-edge technology.
May 12, 2023
Pharmaceutical firms are incorporating AI in their operations to drive better patient outcomes, analyze data, and streamline drug development processes.